Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (4)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Completed8
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (10)

Research Network

Activity Timeline